Takashi Nakamura
机构: Faculty of Pharmaceutical Sciences, Hokkaido University
每年引用次数
引用次数
引用: 3,098
H-指数: 33
I10-指数 : 57
出版物: 74
The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
Takashi Nakamura , Daiki Yamazaki , Jun Yamauchi , Hideyoshi Harashima
Journal of Controlled Release 171 ( 2) 216 -224
58
2013
Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.
Takashi Nakamura , Hiroko Miyabe , Mamoru Hyodo , Yusuke Sato
Journal of Controlled Release 216 149 -157
90
2015
A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.
Shota Warashina , Takashi Nakamura , Yusuke Sato , Yuki Fujiwara
Journal of Controlled Release 225 183 -191
95
2016
Development of a multifunctional envelope-type nano device and its application to nanomedicine
Yusuke Sato , Takashi Nakamura , Yuma Yamada , Hideyoshi Harashima
Journal of Controlled Release 244 194 -204
22
2016
Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model
Takashi Nakamura , Masafumi Fukiage , Yoshiteru Suzuki , Ikuya Yano
Journal of Controlled Release 196 ( 196) 161 -167
13
2014
Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo.
Kazuaki Kajimoto , Yusuke Sato , Takashi Nakamura , Yuma Yamada
Journal of Controlled Release 190 593 -606
39
2014
Nanoparticulation of BCG-CWS for application to bladder cancer therapy.
Takashi Nakamura , Masafumi Fukiage , Megumi Higuchi , Akihiro Nakaya
Journal of Controlled Release 176 44 -53
46
2014
A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy
Hiroko Miyabe , Mamoru Hyodo , Takashi Nakamura , Yusuke Sato
Journal of Controlled Release 184 ( 184) 20 -27
93
2014
Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes
Shiroh Futaki , Yumi Masui , Ikuhiko Nakase , Yukio Sugiura
The Journal of Gene Medicine 7 ( 11) 1450 -1458
63
2005
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy.
Rikito Endo , Takashi Nakamura , Kyoko Kawakami , Yusuke Sato
Scientific Reports 9 ( 1) 11335
40
2019
A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant
Naoya Miura , Sharif M. Shaheen , Hidetaka Akita , Takashi Nakamura
Nucleic Acids Research 43 ( 3) 1317 -1331
32
2015
Glycerol monomycolate, a latent tuberculosis-associated mycobacterial lipid, induces eosinophilic hypersensitivity responses in guinea pigs
Yuki Hattori , Isamu Matsunaga , Takaya Komori , Tetsuo Urakawa
Biochemical and Biophysical Research Communications 409 ( 2) 304 -307
21
2011
Th1-skewed tissue responses to a mycolyl glycolipid in mycobacteria-infected rhesus macaques.
Daisuke Morita , Ayumi Miyamoto , Yuki Hattori , Takaya Komori
Biochemical and Biophysical Research Communications 441 ( 1) 108 -113
8
2013
Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex.
Takashi Nakamura , Rumiko Moriguchi , Kentaro Kogure , Hideyoshi Harashima
International Journal of Pharmaceutics 441 ( 1) 476 -481
25
2013
In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide-Loaded Liposomes and Interleukin-12.
Heba Abdelmegeed , Takashi Nakamura , Hideyoshi Harashima
Journal of Pharmaceutical Sciences 105 ( 1) 250 -256
6
2016
A Microbial Glycolipid Functions as a New Class of Target Antigen for Delayed-type Hypersensitivity
Takaya Komori , Takashi Nakamura , Isamu Matsunaga , Daisuke Morita
Journal of Biological Chemistry 286 ( 19) 16800 -16806
29
2011
Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy.
Kaoru Kigasawa , Kazuaki Kajimoto , Takashi Nakamura , Susumu Hama
Journal of Controlled Release 150 ( 3) 256 -265
32
2011
Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes
Atthachai Homhuan , Kentaro Kogure , Takashi Nakamura , Nilabh Shastri
Journal of Controlled Release 136 ( 1) 79 -85
10
2009
Effects of vacuum environment on small fatigue crack propagation in Ti–6Al–4V
Fumiyoshi Yoshinaka , Takashi Nakamura , Kazuaki Takaku
International Journal of Fatigue 91 29 -38
26
2016
Innovative Technologies in Nanomedicines: from Passive Targeting to Active Targeting/from Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics
Yusuke Sato , Yu Sakurai , Kazuaki Kajimoto , Takashi Nakamura
Macromolecular Bioscience 17 ( 1) 1600179
19
2017